Skip Nav Destination
Issues
1 December 2019
-
Cover Image
Cover Image
ABOUT THE COVER
The cover image was adapted from Figure 1 in the article, "Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas," by Zeng and Liu, and colleagues. The authors identified a high-efficiency DNA damage repair-related risk signature as a predictor for prognosis in lower grade glioma. In Figure 1, the authors applied the LASSO Cox regression algorithm to select the most useful predictive features and identified four genes (CRY2, HDAC1, DCLRE1B, and KPNA2) with nonzero regression coefficients. The study concluded that the DNA damage repair-related signature was an independent and powerful prognostic biomarker in lower grade glioma. The signature may potentially improve risk stratification of patients and provide a more accurate assessment of personalized treatment in the clinic. For more information, see the article beginning on page 2079. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Minireview
Commentary
Research Articles
Breast Cancer in San Francisco: Disentangling Disparities at the Neighborhood Level
Alice Guan; Daphne Lichtensztajn; Debora Oh; Jennifer Jain; Li Tao; Robert A. Hiatt; Scarlett Lin Gomez; Laura Fejerman; for the San Francisco Cancer Initiative Breast Cancer Task Force
Author Choice
The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
Yifei Tan; Xiaoyun Zhang; Wei Zhang; Li Tang; Hanwei Yang; Ke Yan; Li Jiang; Jian Yang; Chuan Li; Jiayin Yang; Tianfu Wen; Huairong Tang; Lunan Yan
A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer
Yiwen Zhang; Cindy Ke Zhou; Emily M. Rencsok; Katja Fall; Tamara L. Lotan; Massimo Loda; Francesca Giunchi; Elizabeth A. Platz; Angelo M. De Marzo; Lorelei A. Mucci; Michelangelo Fiorentino; Ericka M. Ebot
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer
Ana Babic; Michael H. Rosenthal; William R. Bamlet; Naoki Takahashi; Motokazu Sugimoto; Laura V. Danai; Vicente Morales-Oyarvide; Natalia Khalaf; Richard F. Dunne; Lauren K. Brais; Marisa W. Welch; Caitlin L. Zellers; Courtney Dennis; Nader Rifai; Carla M. Prado; Bette Caan; Tilak K. Sundaresan; Jeffrey A. Meyerhardt; Matthew H. Kulke; Clary B. Clish; Kimmie Ng; Matthew G. Vander Heiden; Gloria M. Petersen; Brian M. Wolpin
A Phenome-Wide Mendelian Randomization Study of Pancreatic Cancer Using Summary Genetic Data
Ryan J. Langdon; Rebecca C. Richmond; Gibran Hemani; Jie Zheng; Kaitlin H. Wade; Robert Carreras-Torres; Mattias Johansson; Paul Brennan; Robyn E. Wootton; Marcus R. Munafo; George Davey Smith; Caroline L. Relton; Emma E. Vincent; Richard M. Martin; Philip Haycock
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.